LakeShore Biopharma Co Total Revenue

LakeShore Biopharma Co posts a total revenue of $320M as of March 2024. That compares with $54M in the prior-year period — up 489.2% year over year. That is below the sector sector average of $1.3B. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, LakeShore Biopharma Co's total revenue was $54M. The latest reading is $320M — a 489.2% year-over-year increase (period ending March 2024). Use the history and growth charts on this page for a longer lookback.

For its sector stocks, a total revenue near $1.3B is typical. LakeShore Biopharma Co's $320M is lower that level. That is roughly 76.1% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Total Revenue is one piece of LakeShore Biopharma Co's financial statement story. At $320M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for LSB's total revenue usually means three checks: (1) trend versus prior periods, (2) level versus peers (average $1.3B), and (3) consistency with growth and profitability. This page covers the first two; LakeShore Biopharma Co's other metric pages and overview cover the third.